Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV, Combination Therapy”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT03387462
What this trial is testing

DOT Diary Optimization Pilot: A Pilot Study to Optimize the DOT Diary App to Measure PrEP Adherence

Who this might be right for
Adherence, MedicationRisk BehaviorPre-Exposure Prophylaxis+1 more
Public Health Foundation Enterprises, Inc. 20
Early research (Phase 1)Study completedNCT03307915
What this trial is testing

2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Modified Vaccinia Ankara (MVA)-Mosaic OR Ad26.Mos4.HIV Plus a Combination of Mosaic and Clade C gp140 Protein in Human Immunodeficiency Virus (HIV) Type 1 Infected Adults on Suppressive Antiretroviral Treatment

Who this might be right for
Human Immunodeficiency Virus
Janssen Vaccines & Prevention B.V. 25
Not applicableStudy completedNCT00002068
What this trial is testing

Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis

Who this might be right for
Meningitis, CryptococcalHIV Infections
Pfizer
Not applicableStudy completedNCT00002186
What this trial is testing

Double-Blind Placebo-Controlled Study Comparing the Combination of 15% SP-303 Gel With Acyclovir Versus Acyclovir Alone for the Treatment of Recurrent Herpes Simplex Virus (HSV) Infections in Subjects With Acquired Immunodeficiency Syndrome (AIDS)

Who this might be right for
Herpes SimplexHIV Infections
Shaman Pharmaceuticals 400
Early research (Phase 1)Study completedNCT01982396
What this trial is testing

Pharmacokinetic (PK) Study of Twice Daily vs Once Daily Lamivudine (3TC) and Abacavir (ABC) as Part of Combination Antiretroviral Therapy (ART) in HIV Infected Children

Who this might be right for
HIV Infection
PENTA Foundation 19
Early research (Phase 1)Study completedNCT00000902
What this trial is testing

A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior Treatment

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 217
Post-approval studies (Phase 4)Study completedNCT00869700
What this trial is testing

Pharmacokinetic Interaction Between the Antimalarial Combination Artemether/Lumefantrine and Combination Antiretroviral Therapy Including Lopinavir/Ritonavir in HIV-infected Adults

Who this might be right for
HIV InfectionsMalaria
University of Cape Town 18
Testing effectiveness (Phase 2)Study completedNCT00006144
What this trial is testing

HIV-Disease Development in Aging

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 90
Not applicableStudy completedNCT00001111
What this trial is testing

Nevirapine Used Alone or in Combination With AZT in HIV-1-Infected Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 35
Early research (Phase 1)Study completedNCT00000699
What this trial is testing

A Phase I/II Trial of Ribavirin (With Escalation) + Isoprinosine in Asymptomatic HIV-Viremic Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 20
Large-scale testing (Phase 3)Study completedNCT00002230
What this trial is testing

A Randomized, Placebo-Controlled Study of the Safety and Efficacy of Efavirenz, Didanosine, and Stavudine in Combination With or Without Hydroxyurea in Antiretroviral Naive or Experienced HIV-Infected Patients

Who this might be right for
HIV Infections
Northwestern University 100
Early research (Phase 1)Study completedNCT00002381
What this trial is testing

The Safety and Effectiveness of Nevirapine Plus Nelfinavir in HIV-1 Infected Patients Who Have Taken Stavudine

Who this might be right for
HIV Infections
Boehringer Ingelheim 24
Post-approval studies (Phase 4)Study completedNCT01422330
What this trial is testing

Evaluate the Safety, Tolerability, and Pharmacokinetics of Etravirine Administered in Combination With Other Antiretroviral Agents in Antiretroviral Treatment-Experienced HIV-1 Infected Patients

Who this might be right for
Human Immunodeficiency Virus (HIV) Infection
Janssen R&D Ireland 211
Large-scale testing (Phase 3)Study completedNCT00008528
What this trial is testing

T-20 With Anti-HIV Combination Therapy for Patients With Prior Anti-HIV Drug Treatment and/or Drug Resistance to Each of the Three Classes of Approved Anti-HIV Drugs

Who this might be right for
HIV Infections
Hoffmann-La Roche 525
Testing effectiveness (Phase 2)Study completedNCT00000872
What this trial is testing

Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 55
Post-approval studies (Phase 4)Study completedNCT00002229
What this trial is testing

Safety and Effectiveness of Adding Saquinavir (FORTOVASE) in Soft Gel Capsule Form to an Anti-HIV Drug Combination in HIV-Infected Patients

Who this might be right for
HIV Infections
Hoffmann-La Roche 80
Not applicableStudy completedNCT01204905
What this trial is testing

R5 Integrase Study in HIV-1 Naive Patients

Who this might be right for
HIV Infections
University of Maryland, Baltimore 7
Testing effectiveness (Phase 2)Study completedNCT00001039
What this trial is testing

Evaluation of Treatment for Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Early research (Phase 1)Study completedNCT00002183
What this trial is testing

A Phase I Trial to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of 141W94 After Multiple Dosing in Patients With HIV Infection

Who this might be right for
HIV Infections
Glaxo Wellcome 60
Testing effectiveness (Phase 2)Study completedNCT01391013
What this trial is testing

Compare Brachial Artery Reactivity and Cardiovascular Risk of a Treatment Simplification by Darunavir/Ritonavir (DRV/r) 800/100 mg Versus a Triple Combination Therapy Containing DRV/r in HIV-1 Infected Patients

Who this might be right for
Human Immunodeficiency Virus 1
Janssen-Cilag S.p.A. 30
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation